Top Trends Transforming the Closed System Transfer Devices Market Landscape in 2025: New EQUASHIELD® Syringe Unit Receives FDA Clearance, Enhancing Safety in Hazardous Drug Administration

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Closed System Transfer Devices Industry Market Size Be by 2025?
The market size of closed system transfer devices has seen a swift rise in the recent past. There is an anticipated growth from $1.04 billion in 2024 to reach $1.18 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.7%. The notable growth in the previous period can be linked to a rise in the approvals of oncology drugs, increased focus towards occupational safety, and the need to limit injuries from needles and exposure to dangerous drugs. Furthermore, there is a growing consciousness regarding the potential risks of exposure to cytotoxic drugs. The increase in patient population undergoing chemotherapy has also significantly contributed to this growth.

What's the Long-Term Growth Forecast for the Closed System Transfer Devices Market Size Through 2029?
In the coming years, the market size for closed system transfer devices is anticipated to experience swift expansion, ultimately reaching $1.96 billion in 2029 with a 13.4% compound annual growth rate (CAGR). This forecasted growth can be tied to a rise in cancer incidences, an amplified necessity for enforcing compliance in the safe handling of harmful drugs, an increased awareness towards the application of closed system transfer devices, broadening deployment of CSTDS in transporting perilous medications, and a burgeoning number of drug approvals for cancer treatment. Looking into the forecast period, upcoming trends comprise the introduction of new products and emphasis on safety, the evolution of digital platforms and devices that are easy to use, heightened levels of research and development activity, advancements in technology, and the incorporation of membrane-to-membrane systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

What Are the Key Growth Drivers Fueling the Closed System Transfer Devices Market Expansion?
The escalating prevalence of cancer is predicted to fuel the expansion of the closed-system transfer devices sector. Noted for its unchecked proliferation of abnormal cells, which can impinge surrounding tissues and permeate other body parts through the circulatory and lymphatic systems, cancer incidences are on an upward trajectory due to diverse elements like lifestyle habits, environmental exposure, and elevated infection rates. Closed-system transfer devices play a pivotal role in the therapy of cancer, providing a shield for healthcare professionals and patients from the potential hazards associated with the manipulation and application of chemotherapy drugs. The deployment of these devices ensures a more secure healthcare setting and improved therapy results for individuals suffering from cancer. In February 2024, the World Health Organization (WHO), an intergovernmental organization headquartered in Switzerland, indicated that by 2050, the number of cancer cases is predicted to surpass 35 million, marking a 77% jump from the projected 20 million cases anticipated for 2022. This significant leap accentuates the mounting global burden of cancer. Moreover, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental entity, there were approximately 1,958,310 fresh cancer incidences in the United States and an estimated 609,820 cancer-related fatalities are foreseen to happen in 2023. Consequently, the swelling cancer cases drive the closed system transfer devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

What Are the Key Trends Driving Closed System Transfer Devices Market Growth?
Main players in the closed system transfer devices (CSTD) market are gearing their efforts towards inventing novel syringe units. These units are aimed at augmenting safety, ameliorating end-user experience, mitigating the chance of contamination, and meeting the strict regulatory norms of the healthcare sector. A full-volume use syringe unit is a needle unit built to dispense or apply the aggregate amount of a liquid or drug it holds without calling for any added mixing or dilution. As an illustration, Equashield, a medical device firm based in the US, unveiled the EQUASHIELD Syringe Unit in October 2023. This unit acquired the FDA clearance for full-volume use, facilitating safer and more efficacious management of perilous drugs. Its pioneering structure stops the vapour from leaving and plunger contamination, thus establishing it as a cost-efficient choice for compounding and applying medications.

How Is the Closed System Transfer Devices Market Segmented?
The closed system transfer devices market covered in this report is segmented -

1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based, Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:
1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters
2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

Which Companies Are Leading the Charge in Closed System Transfer Devices Market Innovation?
Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton dic*kinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Which Regions Are Leading the Global Closed System Transfer Devices Market in Revenue?
North America was the largest region in the closed system transfer device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.